The formation of inflammatory demyelinated lesions in cerebral white matter

Pietro Maggi1, Sheila M Cummings Macri, María I Gaitán

  • 1National Institute for Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Department of Neurosciences, Drug Research, and Child's Health, University of Florence, Florence, Italy.

Annals of Neurology
|August 5, 2014
PubMed
Abstract

Insights

In marmoset experimental autoimmune encephalomyelitis (EAE), increased blood-brain barrier permeability precedes demyelination and inflammatory cell infiltration. Early detection of these vascular changes may enable timely intervention in multiple sclerosis (MS) lesions.

Area of Science:

  • Neuroimmunology
  • Neuroinflammation
  • Demyelinating Diseases

Background:

  • Vascular permeability and inflammatory demyelination are linked in the brain.
  • The temporal relationship between these processes in multiple sclerosis (MS) remains unclear.

Purpose of the Study:

  • To determine the earliest radiological correlates of tissue changes in experimental autoimmune encephalomyelitis (EAE), a primate model of MS.
  • To investigate the temporal sequence of blood-brain barrier (BBB) changes and demyelination.

Main Methods:

  • Utilized 7T magnetic resonance imaging (MRI) including T1 maps, proton density, and T2-weighted images in marmosets before and after EAE induction.
  • Measured BBB permeability changes using contrast-enhanced MRI and compared findings with postmortem tissue examination.

Main Results:

  • Blood-brain barrier permeability significantly increased up to 4 weeks before visible lesion appearance.
  • Increased permeability preceded the infiltration of blood-derived monocytes and demyelination.
  • Early perivascular inflammatory foci showed increased permeability without MRI correlates.

Conclusions:

  • Early vascular permeability changes in marmoset EAE precede demyelination and are associated with perivascular inflammation.
  • Prospective detection of transient permeability changes offers potential for early therapeutic intervention in MS lesions.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
17
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
10
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
10
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
16
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
21
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
10